Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Equity (2016 - 2025)

Historic Return on Equity for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to 0.56%.

  • Vanda Pharmaceuticals' Return on Equity fell 5200.0% to 0.56% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.56%, marking a year-over-year decrease of 5200.0%. This contributed to the annual value of 0.51% for FY2025, which is 4700.0% down from last year.
  • According to the latest figures from Q4 2025, Vanda Pharmaceuticals' Return on Equity is 0.56%, which was down 5200.0% from 0.18% recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Return on Equity peaked at 0.07% during Q3 2021, and registered a low of 0.56% during Q4 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' median Return on Equity value was 0.01% (recorded in 2022), while the average stood at 0.03%.
  • In the last 5 years, Vanda Pharmaceuticals' Return on Equity soared by 300bps in 2021 and then crashed by -5200bps in 2025.
  • Vanda Pharmaceuticals' Return on Equity (Quarter) stood at 0.07% in 2021, then crashed by -82bps to 0.01% in 2022, then plummeted by -62bps to 0.0% in 2023, then plummeted by -859bps to 0.04% in 2024, then tumbled by -1488bps to 0.56% in 2025.
  • Its Return on Equity was 0.56% in Q4 2025, compared to 0.18% in Q3 2025 and 0.13% in Q2 2025.